Capital Wired

Keeps You Updated

Friday, February 26, 2021
Log in
  • Headlines
  • Business
  • Health
  • Tech & Science
  • Sports
  • World
  • US
  • Latest News
    • How To Make Your Own Home-Brewed Morphine
    • Using Mouthwash Too Often Puts You at Risk of Obesity and Diabetes
    • Walmart to Solve its Supply Chain Issues and Further Cut Down on Costs
    • The World’s Most Expensive Christmas Decorations
    • Netflix Hopes to Balance Data Limit With Great Video Quality
    • Joji Morishita says Japan Will Resume Whaling
    • The Most Beloved Plastic Surgeries Among Americans
    • Skype for Web Allows Non-Users to Take Part In Its Online Chats

Pages

  • About Capital Wired
  • Contact Us
  • Privacy Policy GDPR
  • Reprint & Licensing
  • Staff
  • Terms of Use

Recent Posts

  • Here’s Why Your Brain Keeps Worrying about Everything June 29, 2018
  • Don’t Throw That Sunscreen after Summer Is Up June 29, 2018
  • Analysts: Currency War between U.S. and China Might Be Looming June 28, 2018
  • Starbucks Rival The Coffee Bean & Tea Leaf Opening 100 Shops June 27, 2018
  • Study Finds We Are Alone in the Universe June 26, 2018
  • Restaurant Owner Not Sorry for Booting Sarah Sanders June 26, 2018
  • Beware of the Hidden Salt in Your Food! June 25, 2018

Keryx Biopharmaceuticals unable to achieve NCE designation

August 16, 2014 By Brian Galloway Leave a Comment

Email, RSS Follow

Keryx Biopharmaceuticals’ intellectual property for Zerenex will provide patent protection until 2024; reaffirm Market Outperform rating and $22 year-end 2014 price target based on DCF and SOTP analyses. Yesterday, Galencia confirmed that its recently approved drug Velphoro was not granted marketing exclusivity as a new chemical entity (NCE) by the FDA.

Keryx-Biopharmaceuticals

Analysts remind investors that a NCE designation confers an additional five years of marketing exclusivity against generic competition. This ruling was based on the rationale that the active ingredient in Velphoro, ferric iron, is already the active ingredient in drugs previously approved by the FDA. While on the surface this may seem to indicate a similar fate for Zerenex, we believe a NCE designation may be less important given two key patents covering the drug substance, surface area, and intrinsic dissolution that are sufficient to protect Zerenex from generic competition until 2024.

These are patents with composition claims that are not process dependent. In addition, Keryx has a method of use patent on Zerenex that, though set to expire in 2017, may be eligible for Patent Term Extension. We remind investors that while NCE designation is administered by the FDA, PTE is determined by the U.S. patent office.

Email, RSS Follow

Brian Galloway

Brian’s philosophy is pretty straightforward: easy living, wishful thinking, heavy criticizing. Despite the fact that he wouldn’t go as far as describe himself a conspirationist, Brian does take everything with a grain of sand. He loves following every lead when covering a story and mostly enjoys to cover politics and US news.

Filed Under: Health Tagged With: Designation, Keryx Biopharmaceuticals, NCE

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Recent Articles

dc logo on black galaxy background

Ava DuVernay to Direct DC’s New Gods Adaptation

March 16, 2018 By Rebecca McGhee Leave a Comment

leonardo davinci's signature in black

Is DaVinci’s Record Breaking Painting Authentic?

November 20, 2017 By Rebecca McGhee Leave a Comment

stephen hawking

Stephen Hawking Makes Gloomy Prediction For Earth In A 100 Years

May 7, 2017 By Deborah Nielsen Leave a Comment

"Dwayne Johnson not dead"

Dwayne Johnson Died this Week or Not

January 19, 2016 By Jason Leathers 3 Comments

There Are At Least Three More Seasons of Game of Thrones To Go

July 31, 2015 By Rebecca McGhee Leave a Comment

Homelessness Soars in L.A., Officials Pledge to House Everybody by 2016

May 12, 2015 By Brian Galloway Leave a Comment

FBI Releases National Report on Slain Police Officers, Figures are Alarming

May 12, 2015 By Rebecca McGhee Leave a Comment

New York Nuclear Plant Partially Shut Down due to Hudson Oil Slick

May 11, 2015 By Jason Leathers 2 Comments

Obama Draws Heat from Democrats over Asia Trade Deal

May 9, 2015 By Rebecca McGhee Leave a Comment

Florida Governor Changes Stance on Obamacare Once More, Budget on Hold

May 9, 2015 By Brian Galloway Leave a Comment

Secret Service to add an Extra Layer of Spikes to White House Fence

May 8, 2015 By Chen Lai Leave a Comment

Police Arrested Suspect in death of Student who tried to Sell Car on Craigslist

May 8, 2015 By Deborah Nielsen 1 Comment

AccuWeather.com: 2015 Atlantic Tropical Storm Season is Officially Open

May 7, 2015 By Deborah Nielsen Leave a Comment

Illinois Student Found Dead after Trying to Sell his Car on Craigslist

May 7, 2015 By Deborah Nielsen 2 Comments

Related Articles

  • Woman drinking coffee

    Here’s Why Your Brain Keeps Worrying about Everything

    Jun 29, 2018
  • Expiry date on sunscreen bottle

    Don’t Throw That Sunscreen after Summer Is Up

    Jun 29, 2018
  • U.S. President Donald Trump smiling

    Analysts: Currency War between U.S. and China Might Be Looming

    Jun 28, 2018
  • Kitchen salt

    Beware of the Hidden Salt in Your Food!

    Jun 25, 2018
  • Giant Hogweed

    Blindness-Causing Toxic Weed Spotted for the First Time in VA

    Jun 22, 2018
  • Pot leaves

    Pot Users More Sensitive to Pain (Study)

    Jun 22, 2018
  • Fasting diet

    16:8 Diet Can Help You Lose Weight without Hassle (Study)

    Jun 19, 2018
  • Mother and toddler

    Helicopter Parents Can Wreak Havoc on Kids’ Emotional Health, Study

    Jun 19, 2018
  • Young woman getting a tan

    Vitamin D Deficiency Tied to Higher Colon Cancer Risk

    Jun 15, 2018
  • Kitchen towels

    Kitchen Towels Are Breeding Grounds for Disease-Causing Bacteria, Study

    Jun 13, 2018

Categories

  • Business
  • Headlines
  • Health
  • Sports
  • Tech & Science
  • US
  • World

Copyright © 2021 capitalwired.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.